Translational pharmacogenetic analysis in the CANTO (CANcer TOxicities) cohort, to quantify and to predict treatment-related chronic toxicities in patients with non-metastatic breast cancer. The pharmacogenetics component of the CANTO project was set up with Professor Gilles Thomas who passed away in 2014.
